Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingShares Repurchased
Ratios

SBC Medical Group Holdings (SBCWW) EBIAT (2023 - 2025)

Historic EBIAT for SBC Medical Group Holdings (SBCWW) over the last 3 years, with Q3 2025 value amounting to $12.8 million.

  • SBC Medical Group Holdings' EBIAT rose 35275.98% to $12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.3 million, marking a year-over-year decrease of 2046.16%. This contributed to the annual value of $46.7 million for FY2024, which is 1859.25% up from last year.
  • SBC Medical Group Holdings' EBIAT amounted to $12.8 million in Q3 2025, which was up 35275.98% from $2.5 million recorded in Q2 2025.
  • SBC Medical Group Holdings' 5-year EBIAT high stood at $21.5 million for Q1 2025, and its period low was $196786.0 during Q2 2023.
  • Moreover, its 3-year median value for EBIAT was $8.4 million (2023), whereas its average is $9.7 million.
  • As far as peak fluctuations go, SBC Medical Group Holdings' EBIAT surged by 933020.59% in 2024, and later plummeted by 8675.33% in 2025.
  • SBC Medical Group Holdings' EBIAT (Quarter) stood at $14.3 million in 2023, then plummeted by 54.35% to $6.5 million in 2024, then surged by 95.99% to $12.8 million in 2025.
  • Its EBIAT was $12.8 million in Q3 2025, compared to $2.5 million in Q2 2025 and $21.5 million in Q1 2025.